Dipyridamole Injection
- Packing: 2 Ml Ampoule.
- Available Strength : 5 Mg/Ml
Description
Product Description: Our Dipyridamole Injection is a pharmaceutical formulation meticulously crafted to address thromboembolic disorders effectively. It contains dipyridamole, a potent platelet aggregation inhibitor and vasodilator, known for its role in preventing blood clot formation. Manufactured to the highest quality standards, this injection is trusted by healthcare professionals for its reliability and efficacy in thromboprophylaxis and cardiovascular health management.
Indications and Usage: Dipyridamole Injection is indicated for the prevention of thromboembolic events in patients at risk of arterial or venous thrombosis, including those with a history of myocardial infarction, stroke, or transient ischemic attack. Additionally, it is used in combination with anticoagulant therapy to reduce the risk of thrombosis in patients undergoing cardiac valve replacement surgery.
Dosage and Administration: The dosage of Dipyridamole Injection varies depending on the patient's clinical condition, age, and concurrent medications. It is typically administered via intravenous infusion at a prescribed rate under the supervision of a qualified healthcare professional. Dosage adjustments may be necessary based on the patient's response to therapy and individual tolerance.
Dosage Forms and Strengths: Dipyridamole Injection is available as a sterile solution in vials containing a specific concentration of dipyridamole formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to dipyridamole or any of the excipients. It should not be used in patients with severe coronary artery disease, unstable angina, or recent myocardial infarction. Additionally, it is contraindicated in patients with acute myocardial infarction accompanied by left ventricular dysfunction.
Warnings and Precautions: Healthcare providers should exercise caution when prescribing Dipyridamole Injection to patients with a history of bleeding disorders, peptic ulcer disease, or liver dysfunction. Prolonged use may lead to an increased risk of bleeding, especially when used concomitantly with anticoagulant therapy. Patients should be monitored closely for signs of bleeding during therapy.
Adverse Reactions/Side Effects: Common adverse reactions associated with Dipyridamole Injection include headache, dizziness, gastrointestinal disturbances, and flushing. Rarely, serious adverse effects such as allergic reactions, hypotension, and bradycardia may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Concomitant use of Dipyridamole Injection with other drugs that affect platelet function or coagulation may increase the risk of bleeding or potentiate the effects of dipyridamole. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.
Use In Specific Populations Description: Safety and efficacy of Dipyridamole Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Dipyridamole Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.
